Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Outlook on the Next-Generation Sequencing Global Market to 2025 – Featuring Agilent Technologies, Novogene and Oxford Nanopore Technologies Among Others

Published

on

Dublin, June 11, 2021 (GLOBE NEWSWIRE) — The “Next-Generation Sequencing: Emerging Clinical Applications and Global Markets 2020-2025” report has been added to ResearchAndMarkets.com’s offering.

The global market for clinical next-generation sequencing (NGS) should grow from $5.9 billion in 2020 to $22.9 billion by 2025 with a compound annual growth rate (CAGR) of 31.4% for the period of 2020-2025.

The scope of the report includes clinical NGS technologies, applications, industries, initiatives, patents and companies. The markets for NGS-based diagnostics are given for the years 2019, 2020 and 2025.

This report reviews the main sequencing technologies and explains why genetic variation is important in clinical testing. It then discusses some of the significant research initiatives that impact clinical NGS applications. Liquid biopsy formats are discussed. The main market driving forces are also discussed.

The report examines the markets by test complexity, clinical indication and test purpose. Test complexity refers to the plex level (i.e., the number of genetic markers that can be analyzed within a sample) and coverage (e.g., the extent to which the genome is covered) of the test. Examining the market by test complexity provides valuable insight into which products (e.g., sample preparation, NGS instrument, informatics, etc.) will be in demand in the future.

The report provides market data and forecasts for NGS diagnostics by specific applications, including those for oncology, cardiovascular diseases, clinical microbiology/infectious diseases, Mendelian disorders, metabolic/immune disorders, neurological disorders, reproductive health and transplant medicine.

Advertisement
Stake.com

Specific geographic markets are discussed, including North America, Europe, Asia-Pacific and the rest of the world.

Industry sectors analyzed include DNA sequencing instruments; long-read sequencing; sequencing informatics; target enrichment; CTC capture and detection; liquid biopsy; cancer screening/early detection; direct to consumer testing; and noninvasive prenatal testing.

The Report Includes

  • 29 data tables and 73 additional tables
  • An updated review of the global market for emerging clinical applications of the next-generation sequencing (NGS) based diagnostics and related technologies
  • Analyses of the global market trends, with data from 2019-2020, and projections of compound annual growth rates (CAGRs) through 2025
  • Discussion of market opportunities for clinical NGS products, clinical applications, industry structure, regulatory scenario, and penetration of NGS-based diagnostics and technologies within the industry
  • Estimation of the current market size and revenue forecasts for the global NGS diagnostic markets, and corresponding market share analysis by disease indication, test complexity, test purpose, application and geographic region
  • Evaluation of the key NGS workflow portions of the industry (e.g., sequencing instruments, pre-sequencing target preparation and capture, and post-sequencing data analysis) and the main clinical indications where NGS will capture significant market share by 2025
  • Assessment of main sequencing technologies and explanation of the importance of genetic variation in clinical testing as well as some of the significant research initiatives affecting clinical NGS applications
  • A summary of the major acquisitions and strategic alliances in the clinical NGS industry from January 2019 through April 2021, including key alliance trends
  • Patent review and significant allotments of the U.S. patents in the liquid biopsy industry
  • Company profiles of the major market players, including Agilent Technologies Inc., Becton, Dickinson and Co. (BD), Koninklijke Philips N.V., Merck KGaA, Novogene Co. Ltd., Oxford Nanopore Technologies Ltd., Qiagen NV, Roche Holding AG, and Thermo Fisher Scientific Inc.

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Advertisement
Stake.com

Chapter 3 Overview

  • Introduction
  • Liquid and Tissue Biopsy
  • Clinical NGS Testing Market
  • Growth Drivers of Clinical NGS
  • Key Trends
  • Industry

Chapter 4 Technology Background

  • Importance of DNA
  • Genetic Variation and Analysis
  • Genetic Analysis Technologies
  • Sequencing in Clinical Applications
  • Sequencing Technologies
  • History of DNA Sequencing
  • Sanger Sequencing Technology
  • NGS Platforms
  • Short-Read Platforms
  • Long-Read Platforms
  • Informatics Technologies
  • Base Calling
  • Mapping to a Reference Sequence
  • Variant Analysis
  • Artificial Intelligence Technologies
  • Clinical Sequencing Technology Challenges

Chapter 5 Clinical NGS Initiatives

  • R&D Initiatives and Programs
  • 1+ Million Genomes
  • Access to Treatment and Testing (ACTT)
  • Access to Comprehensive Genomic Profiling Coalition (ACGP)
  • Africa Pathogen Genomics Initiative
  • Blood Profiling Atlas
  • Cancer-ID
  • Cancer Moon Shots Program
  • China Precision Medicine Initiative
  • ClinGen
  • CTC Trap Consortium
  • diaRNAgnosis Project
  • Early Cancer Detection Consortium
  • EpiFemCare
  • France Genomic Medicine Plan
  • Friends of Cancer Research Project
  • Genomic Medicine Sweden
  • HCA-Organoid
  • Human Cell Atlas
  • Human Immunomics Initiative
  • Immunomonitor Consortium
  • Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy Program
  • Intervene
  • Liquid Biopsies and Imaging for Improved Cancer Care
  • Liquid Biopsy-Based Malignant Tumor Early Screening Technology Research and Development Project
  • Liver Cancer Early Screening Comprehensive Prevention and Control Project
  • Lung Cancer Genomic Screening Project for Individualized Medicine in Asia
  • Million Veteran Program
  • Medical Genome Initiative
  • MedSeq
  • Precision Medicine Initiative
  • Prompt
  • QuIP Project
  • SPHERES
  • Target ALS Diagnosis Initiative
  • TopMed
  • Treehouse Childhood Cancer Initiative
  • Very Rare Cancer Consortium
  • Worldwide Innovative Networking (WIN) Consortium
  • Single-Cell Research
  • Cambridge Single-Cell Analysis Core Facility
  • Harvard Medical School Single-Cell Core
  • Mayo Medical Genome Facility
  • National Center for Single-Cell Biology
  • Next-Generation Single-Cell Analysis Program
  • Single-Cell Analysis Core
  • UC San Francisco Single-Cell Analysis Center
  • Population Sequencing Projects

Chapter 6 Clinical NGS Applications

  • Introduction
  • Cancer Applications
  • Precision Medicine
  • Liquid Biopsy Biomarkers
  • Mendelian Disorders Applications
  • Reproductive Health Applications
  • Noninvasive Prenatal Testing
  • Newborn Screening
  • Microbiology and Infectious Disease Applications
  • Complex Disorders Applications

Chapter 7 Clinical NGS Industry

  • Sequencing Instrument Industry
  • Companies
  • Third-Generation Sequencing Industry
  • Sequencing Informatics Industry
  • Target Enrichment and Amplification Industry
  • CTC Capture and Detection Industry
  • Liquid Biopsy Assay Industry
  • Liquid Biopsy Cancer Screening/Early Detection Industry
  • Health-Focused DTC Genetic Testing Industry: Two Market Models
  • DTC Clinical Health Genetic Testing Industry
  • Noninvasive Prenatal Testing (NIPT) Industry

Chapter 8 Acquisitions and Strategic Alliances

  • Acquisitions
  • Strategic Alliances
  • Key Trends

Chapter 9 Clinical NGS Markets

  • Market Dynamics
  • Market Drivers
  • Impact of COVID-19 on the Clinical NGS Markets
  • Clinical NGS Market by Disease Category
  • Oncology
  • Cardiology
  • NGS Mendelian Disorders
  • Metabolic/Immune Disorders
  • Neurology
  • Reproductive Health
  • Microbiology and Infectious Diseases
  • Transplantation
  • Geographical Markets
  • Global Market for NGS in Oncology by Region
  • Global Market for NGS in Reproductive Health by Region

Chapter 10 Patent Review

  • Patents on Circulating Tumor Cells
  • Patents on Exosomes
  • Patents on Cell-Free DNA
  • Patents Related to Biomarkers
  • Patent Considerations for the Use of Artificial Intelligence in Cancer Diagnostics
  • Liquid Biopsy Patent Litigation

Chapter 11 Company Profiles

  • Accuragen Inc.
  • Adaptive Biotechnologies Inc.
  • Agilent Technologies Inc.
  • Alcediag
  • Ambry Genetics
  • Amoy Diagnostics Co. Ltd.
  • Angle Plc
  • Apocell Inc.
  • Apostle Inc.
  • Arcedi Biotech Aps
  • Archer Dx
  • Armonica Technologies Inc.
  • Arup Laboratories
  • Asuragen Inc.
  • Aviva Biomed Inc.
  • Aviva Biosciences
  • Bard1 Life Sciences Ltd.
  • Base Genomics
  • Baylor Genetics
  • Becton, Dickinson And Co.
  • Berry Genomics Co. Ltd.
  • BGI Shenzhen
  • Biocaptiva Ltd.
  • Biocept Inc.
  • Biodesix Inc.
  • Biofluidica Inc.
  • Biolidics Ltd.
  • Biological Dynamics Inc.
  • Bionano Genomics
  • Bio-Techne Corp.
  • Bitbiome, Inc.
  • Bluestar Genomics Inc.
  • Burning Rock Biotech Ltd.
  • C2I Genomics
  • Cambridge Epigenetix
  • Cancer Genetics Inc.
  • Canexia Health
  • Capio Biosciences
  • Captis Diagnostics Inc.
  • Caredx Inc.
  • Caris Life Science
  • Cegat Gmbh
  • Cellmax Life
  • Cell Microsystems Inc.
  • Celsee Diagnostics
  • Centrillion Genomics Technologies
  • Chronix Biomedical
  • Circulogene Theranostics
  • Claret Bioscience
  • Clinical Genomics Technologies
  • Codiak Biosciences
  • Cogenica
  • Cradle Genomics
  • Cyclomics
  • Cygnus Biosciences Co. Ltd.
  • Cytotrack Aps
  • Danaher Corp.
  • Dante Labs
  • Datar Cancer Genetics Ltd.
  • Delfi Diagnostics
  • Diacarta Inc.
  • Diagnologix Llc
  • Diagnomics
  • Diamir Bio
  • Dnalytics
  • Dnanexus Inc.
  • Dovetail Genomics Llc
  • Earlydx Inc.
  • Eone-Diagnomics Genome Center
  • Encrypgen
  • Epic Sciences Inc.
  • Epigenomics Ag
  • Eurofins Scientific
  • Exact Sciences Corp.
  • Exosome Sciences Inc.
  • Exosomics Spa
  • Exopert
  • Ezlife Bio Inc.
  • Fabric Genomics
  • Fluxion Biosciences Inc.
  • Freenome Inc.
  • Fulgent Genetics Inc.
  • Full Genomes Corp. Inc.
  • Genapsys Inc.
  • Gene By Gene Ltd.
  • Genedx Inc.
  • Genetron Health Technologies
  • Geneseq Biosciences Pty Ltd.
  • Genexosome Technologies Inc.
  • Genomictree
  • Genomoncology
  • Genosaber
  • Genosity
  • Grail Inc.
  • Guardant Health Inc.
  • Helio Health
  • Helix Opco Llc
  • Hitgen
  • Htg Molecular Diagnostics Inc.
  • Id Solutions
  • Illumina Inc.
  • Incelldx Inc.
  • Inex Innovate Pte. Ltd.
  • Inivata Ltd.
  • Insitome Inc.
  • Interpace Biosciences Inc.
  • Invitae Inc.
  • Invivoscribe Inc.
  • Jabrehoo Medtech Co., Ltd.
  • Jbs Science Inc.
  • Jumpcode Genomics Inc.
  • Koninklijke Philips N.V.
  • Laboratory Corp. Of America Inc.
  • Labgenomics Co., Ltd.
  • Labrinth Biotech Inc.
  • Lariat Biosciences Inc.
  • Liquid Biopsy Labs
  • Lucence Diagnostics Pte. Ltd.
  • Lunglife Ai Inc.
  • Macrogen Inc.
  • Mapmygenome
  • Mdxhealth Inc.
  • Medgenome Inc.
  • Menarini Silicon Biosystems Spa
  • Merck Kgaa
  • Micareo Rare Cell Diagnostics
  • Micronoma
  • Mir Scientific
  • Mutantdx
  • Myriad Genetics Inc.
  • Namocell Inc.
  • Nanostring Technologies Inc.
  • Nanoview Biosciences Inc.
  • Natera Inc.
  • Nebula Genomics
  • Neogenomics Laboratories
  • Neo New Oncology Gmbh
  • New England Biolabs
  • New Horizon Health Ltd.
  • Nipd Genetics
  • Novigenix Sa
  • Novogene Co. Ltd.
  • Nrichdx Inc.
  • Nuprobe Inc.
  • Nx Prenatal Inc.
  • Oncimmune Holdings Plc
  • Oncocyte Corp.
  • Oncodna S.A.
  • Opko Health
  • Orchid Health Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences Of California Inc.
  • Pangaea Oncology
  • Personal Genome Diagnostics Inc.
  • Personalis Inc.
  • Pfdena Inc.
  • Phase Scientific
  • Phosphorus Inc.
  • Pieriandx
  • Pwnhealth
  • Predicine Inc.
  • Prenetics Group
  • Qcdx Llc
  • Qiagen Nv
  • Quantapore Inc.
  • Quantgene Inc.
  • Quantum Biosystems Inc.
  • Quantumdx
  • Quest Diagnostics Inc.
  • Rarecells Sas
  • Ravgen
  • Real Time Genomics Inc.
  • Resolution Bioscience Inc.
  • Roche Holding Ag
  • Saga Diagnostics Ab
  • Sano Genetics
  • Sanomics Ltd.
  • Screencell
  • Seekin
  • Seracare Life Sciences Inc.
  • Sequencing.Com
  • Seven Bridges Genomics Inc.
  • Single Technologies
  • Singlera Genomics Inc.
  • Smartcactch
  • Stage Zero Life Sciences
  • Strand Life Sciences Pvt. Ltd.
  • Strata Oncology
  • Stratos Genomics Inc.
  • Syapse
  • Sysmex Inostics Gmbh
  • Tailai Biosciences Co., Ltd.
  • Takara Bio Inc.
  • Telexos Gmbh
  • Thermo Fisher Scientific Inc.
  • Twinstrand Biosciences
  • Twist Bioscience
  • Ubiquity Genomics Inc.
  • Universal Diagnostics Sl
  • Vela Diagnostics
  • Veracyte
  • Volitionrx
  • Vortex Biosciences
  • Xing Technologies Llc
  • Yourgene Health Plc
  • Yikon Genomics Co. Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/uh658b


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Complyport’s new AI tool – ViCA.Chat – set to revolutionise compliance support services

Published

on

complyport’s-new-ai-tool-–-vica.chat-–-set-to-revolutionise-compliance-support-services

LONDON, June 14, 2024 /PRNewswire/ — ViCA.Chat, the Virtual Compliance Assistant powered by AI technology, is set to transform regulatory compliance consulting. Developed by ComplyMAP Group’s AI engineers and Complyport’s compliance consulting teams, ViCA redefines compliance support services and propels governance, risk and compliance consulting into a new era of innovation. 

Offering real-time assistance across a vast array of UK and EU regulatory frameworks, ViCA delivers unparalleled efficiency, detail and precision in disentangling and dealing with complicated regulatory frameworks.
The key differentiator of ViCA is its specialised and purposely constructed unique databases that leverage Complyport’s 22 years of regulatory expertise, combined with tailored AI training tools, enabling ViCA to operate as an experienced compliance consultant. A dedicated human support team continuously improves and updates ViCA’s knowledge and responses through a feedback loop process and quality assurance sessions. This powerful symbiosis of AI and human expertise sets ViCA apart and ensures businesses have the latest regulatory information instantaneously and seamlessly.
As a result, ViCA’s specialised regulatory database goes beyond readily available online resources which feature into traditional AI tools. ViCA offers exclusive insights, proprietary regulatory interpretations, historical data, bespoke and purposely structured compliance documentation and templates. With advanced scraping capabilities, ViCA also extracts relevant data from selected websites and publicly available information, ensuring an up-to-date and comprehensive understanding of compliance requirements across industries.
From agile fintech startups to established law firms, financial institutions, regulatory bodies, insurance providers, as well as compliance consultants, ViCA seamlessly adapts to unique compliance needs. Its user-friendly interface ensures navigating and analysing regulatory data is swift and intuitive, streamlining the compliance workflow.
“ViCA is a game-changer in how regulatory compliance advice will be provided in the future”, commented Luis Parra, Managing Director of ViCA. “With ViCA, compliance insights become available to all. No longer are regulated firms and responsible people overly dependent on advisors and compliance consultants. Through ViCA, the financial system will not only meet but exceed regulatory standards. Moreover, the level of information made available to the public will benefit society as a whole, in its interactions with the financial services sector.”
Among ViCA’s revolutionary features is its cost-effective model, allowing businesses to significantly reduce reliance on traditional spending with external consultants and advisors.
Visit ViCA.Chat to experience the future of compliance support.
Contact:
Name: Luis ParraTitle: Managing DirectorCompany: Vica.ChatTelephone: +44 20 7399 4980 Email: [email protected]
About ViCA.Chat:
ViCA.Chat is a revolutionary Virtual Compliance Assistant powered by cutting-edge AI technology, designed to demystify the complexities of regulatory compliance. Utilising Complyport’s 22 years of regulatory expertise, ViCA offers real-time assistance and guidance across a wide range of regulatory frameworks, setting a new standard for efficiency and precision in compliance support. From fintech start-ups to established law firms, financial services institutions, regulators, regulatory firms, compliance consultants and insurance firms, ViCA caters to the diverse needs of professionals across all levels in the broader UK financial services sector.
Visit ViCA.Chat to learn more.
Logo – https://mma.prnewswire.com/media/2439008/ViCA_Logo.jpg

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/complyports-new-ai-tool—vicachat—set-to-revolutionise-compliance-support-services-302173182.html

Continue Reading

Artificial Intelligence

LoRa and LoRaWAN IoT Market worth $32.7 billion by 2029- Exclusive Report by MarketsandMarkets™

Published

on

lora-and-lorawan-iot-market-worth-$32.7-billion-by-2029-exclusive-report-by-marketsandmarkets™

CHICAGO, June 14, 2024 /PRNewswire/ — The LoRa and LoRaWAN IoT Market is expected to reach USD 32.7 billion by 2029 from USD 8.0 billion in 2024, at a Compound Annual Growth Rate (CAGR) of 32.4 % during 2024–2029, according to a new report by MarketsandMarkets™.

Browse in-depth TOC on “LoRa and LoRaWAN IoT Market”
320 – Tables 58 – Figures294 – Pages
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144298529
Scope of the Report
Report Metrics
Details
Market size available for years
2018-2029
Base year considered
2023
Forecast period
2024–2029
Forecast units
Value (USD Billion)
Segments Covered
Offering, Network Deployment, Application, End User, and Region
Region covered
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.
List of Companies in LoRa and LoRaWAN IoT
The Bosch Group (Germany),  Cisco (US), Orange SA (France), Comcast Corporation (US), Semtech (US), NEC Corporation(Japan), Tata Communications (India), AWS (US), Advantech (Taiwan), SK Telecom (South Korea), Murata (Japan), Kerlink (France), Actility (France), Digi International (US), MultiTech (US), Ezurio (US), Sensoterra (Netherlands), Nwave Technologies (US), RAKwireless (China), TheThings.io (Spain), Datacake (Germany), Milesight (China), LORIOT (Switzerland), Exosite (US), Orbiwise (Switzerland), Netmore Group (Sweden), and Radio Bridge Inc (US).
The LoRaWAN ecosystem influences development of tools, software libraries, and cloud-based platforms that streamline the creation, deployment, and management of IoT solutions. Continuously evolving, this ecosystem boasts a burgeoning array of vendors providing LoRa-compliant devices, gateways, and network management solutions. This vibrant competition within the ecosystem propels innovation while driving down costs for end-users. Moreover, the development of interoperable solutions fosters seamless integration and deployment of LoRaWAN networks, simplifying the implementation process for businesses and organizations. As the ecosystem continues to expand and mature, it empowers developers, system integrators, and IoT enthusiasts to unleash their creativity, accelerate time-to-market, and unlock the full potential of LoRaWAN technology in diverse applications and industries.
Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=144298529
Based on network deployment, the public network segment to hold the largest market size during the forecast period.
The robust security features integrated into public LoRaWAN networks play a significant role in driving the growth and adoption of LoRaWAN technology in the market. End-to-end encryption ensures that data transmitted between devices and gateways is protected from unauthorized access or interception, safeguarding sensitive information such as sensor readings, location data, and command messages. Message integrity checks verify the integrity of data packets, detecting any tampering or alteration during transmission and ensuring data authenticity and reliability. Additionally, mutual authentication mechanisms establish trust between devices and gateways, verifying the identity of both parties before allowing communication to occur. These security measures provide organizations and end-users with confidence in the integrity and confidentiality of their data, mitigating concerns related to data privacy, cybersecurity threats, and regulatory compliance. As a result, implementing robust security features in public LoRaWAN networks enhances trust and credibility in the technology, driving increased adoption and market growth as organizations seek reliable and secure connectivity solutions for their IoT deployments.
By offering, the services segment is expected to hold a higher growth rate during the forecast period.
IoT service providers are pivotal in driving adoption by developing vertical-specific solutions finely tuned to the distinct needs of industries like agriculture, healthcare, logistics, and smart cities. In agriculture, for instance, IoT services offer solutions for precision farming, crop monitoring, and livestock management, enabling farmers to optimize irrigation, monitor soil health, and enhance yields. Similarly, IoT services facilitate remote patient monitoring, asset tracking, and inventory management in healthcare, improving patient care, reducing costs, and ensuring compliance with regulatory standards such as HIPAA. In logistics, IoT services provide real-time tracking of shipments, fleet management, and predictive maintenance, enhancing supply chain visibility, efficiency, and reliability. For smart cities, IoT services offer solutions for traffic management, waste management, energy optimization, and public safety, transforming urban infrastructure and enhancing the quality of life for residents. By addressing industry-specific challenges, compliance requirements, and use cases, vertical-specific IoT solutions deliver tangible business value, driving adoption and fueling the growth of the IoT services market across diverse sectors.
Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=144298529
Asia Pacific is expected to hold a higher growth rate during the forecast period.
In the Asia Pacific region, where agriculture serves as a cornerstone of many economies, adopting IoT technologies, particularly LoRa and LoRaWAN, is revolutionizing traditional farming practices. LoRaWAN’s long-range connectivity and low-power consumption make it well-suited for deployment in rural agricultural settings, where access to reliable connectivity may be limited. Through LoRa-based IoT solutions, farmers can implement precision agriculture techniques to address pressing challenges such as water scarcity, soil degradation, and unpredictable weather patterns. LoRa-enabled sensors facilitate real-time monitoring of soil moisture levels, temperature, and humidity, allowing farmers to optimize irrigation schedules and conserve water resources. Remote sensing technologies powered by LoRaWAN enable farmers to gather actionable insights on crop health, pest infestations, and nutrient deficiencies, facilitating timely interventions and improving overall crop management practices. Furthermore, LoRa-based crop analytics platforms provide farmers with data-driven decision support tools, helping them optimize planting strategies, improve yield forecasting, and mitigate the impact of climate change on agricultural productivity. By harnessing the power of LoRa and LoRaWAN IoT solutions, farmers in the Asia Pacific region can increase yields, conserve resources, and enhance resilience to environmental challenges, driving the adoption and growth of the LoRaWAN IoT market in the agricultural sector.
Top Key Companies in LoRa and LoRaWAN IoT Market:
The major vendors covered in the LoRa and LoRaWAN IoT Market are The Bosch Group (Germany),  Cisco (US), Orange SA (France), Comcast Corporation (US), Semtech (US), NEC Corporation(Japan), Tata Communications (India), AWS (US), Advantech (Taiwan), SK Telecom (South Korea), Murata (Japan), Kerlink (France), Actility (France), Digi International (US), MultiTech (US), Ezurio (US), Sensoterra (Netherlands), Nwave Technologies (US), RAKwireless (China), TheThings.io (Spain), Datacake (Germany), Milesight (China), LORIOT (Switzerland), Exosite (US), Orbiwise (Switzerland), Netmore Group (Sweden), and Radio Bridge Inc (US). These players have adopted various growth strategies, such as partnerships, agreements and collaborations, new product launches, enhancements, and acquisitions to expand their footprint in the LoRa and LoRaWAN IoT Market.
Browse Adjacent Markets: Digitalization and Internet of Things (IoT) Market Research Reports & Consulting
Related Reports:
Perimeter Security Market- Global Forecast to 2029
Smart Cities Market – Global Forecast to 2028
Fleet Management Market – Global Forecast to 2028
Smart Water Management Market – Global Forecast to 2028
Rail Asset Management Market – Global Forecast to 2026
Get access to the latest updates on LoRa and LoRaWAN IoT Companies and LoRa and LoRaWAN IoT Industry
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:Mr. Aashish MehraMarketsandMarkets™ INC.630 Dundee RoadSuite 430Northbrook, IL 60062USA: +1-888-600-6441Email: [email protected] Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg

View original content:https://www.prnewswire.co.uk/news-releases/lora-and-lorawan-iot-market-worth-32-7-billion-by-2029–exclusive-report-by-marketsandmarkets-302172905.html

Continue Reading

Artificial Intelligence

Scoring a Seat at UEFA EURO 2024™ with Top-Performing AI-Powered TOSHIBA TV Lineup

Published

on

scoring-a-seat-at-uefa-euro-2024™-with-top-performing-ai-powered-toshiba-tv-lineup

HONG KONG, June 14, 2024 /PRNewswire/ — Football fans are in for a treat as they gear up for UEFA EURO 2024™ with Toshiba TV’s top-performing Gaming TV Z670. As the OFFICIAL TV OF UEFA EURO 2024™, Toshiba TVs present immersive viewing of the football game by their AI-powered TV lineup. To celebrate the brilliant moments it can bring, Toshiba TV are gifting USD100 Amazon Gift Card via their social platform! By simply like, follow and comment on @ToshibaTVGlobal, fans can boost their chances of scoring this prize.

Optimized Visuals Tailored for Football Dynamics
The Toshiba REGZA Engine ZRi in Z670 transports football fans into the heart of the action. With the AI Football Mode, they’ll be able to see fast-moving objects crystal clear and football field actions much enriched. To see their favourite player score that winning goal, the AI Picture Optimizer automatically adjusts visual contrast and precision adapted to the game. From vivid green fields and vibrant player kits, every play comes to life with AI 4K Upscaling and Quantum Dot Color, transforming lower-resolution broadcasts into near-4K quality and unleashing lifelike visual color.
Powerful Audio Effects for a Live Stadium Experience
The Toshiba TV Z670’s powerful audio system makes viewers feel like they’re right in the game. With the REGZA Bass Woofer Pro, Tru Bass Booster, and Dolby Atmos, they’ll experience heart-thumping 3D surround sound that captures the live stadium atmosphere. Whether it’s the roar of the crowd or the intensity of each play, the rich audio brings the excitement of each game right into their room.
Bringing Everyone Together for UEFA EURO 2024™
Available in sizes ranging from 55″ to 85″, Z670 is equipped with a Wide Viewing Angle and Anti-reflection features that ensures a clear picture from all viewing positions with the non-glare panel. Gather everyone for “Brilliant Every Moment” in UEFA EURO 2024™ with Toshiba TV!
Please find the high-resolution TVC here: Link
About Toshiba TV:
With 70+ years of history in TV production, Toshiba TV is known for its exquisite craftsmanship, innovative ideas and groundbreaking inventions. By prioritizing superior image quality and auditory experiences, Toshiba TV sets new standards in entertainment. Toshiba TV stems from the excellence quest of customers, providing the world with responsible products to make the world a better place. Emphasizing attention to product details and technological advancement, Toshiba TV integrates aesthetically pleasing design, quality assurance, and brand reputation to underscore its commitment to authenticity in the actual world and a sincere dedication to its consumers, showcasing Toshiba TV’s long-standing design philosophy and continuous pursuit of product quality.
Photo – https://mma.prnewswire.com/media/2438761/image_5030810_27421259.jpgLogo – https://mma.prnewswire.com/media/2438760/image_5030810_27421181_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/scoring-a-seat-at-uefa-euro-2024-with-top-performing-ai-powered-toshiba-tv-lineup-302172970.html

Continue Reading

Trending